A New Test Could Save Arthritis Patients Time, Money, and Pain. But Will It Be Used?
Stories of chronic pain, drug-hopping, and insurance meddling are all too common among patients with rheumatoid arthritis. Precision medicine offers new hope.
Drugs
201 - 220 of 1,305 Results
-
-
-
-
Colorado Blames Biden Team and Drugmakers for Delaying Canadian Imports
Colorado officials say they haven鈥檛 been able to stand up a program to import drugs from Canada because of drugmaker opposition 鈥 and the Biden administration鈥檚 inaction.
-
These Programs Put Unused Prescription Drugs in the Hands of Patients in Need
States and counties look to expand programs that accept donations of unused surplus drugs from places like nursing homes and hospitals and redistribute them to low-income and uninsured residents.
By Kate Ruder -
Readers Slam Hospital Monopolies and Blame the Feds for Understaffed Nursing Homes
吃瓜不打烊 gives readers a chance to comment on a recent batch of stories.
-
Watch and Listen: Opioid Settlement Case Triggers Protests Outside the High Court
The Supreme Court heard arguments over whether the Sacklers, the family behind Purdue Pharma 鈥 which marketed OxyContin 鈥 could claim immunity from future lawsuits without claiming bankruptcy.
-
-
Many Autoimmune Disease Patients Struggle With Diagnosis, Costs, Inattentive Care
Despite the prevalence of autoimmune conditions, like the thyroid disease Hashimoto鈥檚, sometimes finding help can prove frustrating as well as expensive. There are often no definitive diagnostic tests, so patients may rack up big bills as they search for confirmation of their condition and for treatment options.
By Andy Miller -
Health Care Is Front and Center as DeSantis and Newsom Go Mano a Mano
Florida鈥檚 Republican Gov. Ron DeSantis and California鈥檚 Democratic Gov. Gavin Newsom will square off in a first-of-its-kind debate on Nov. 30. 吃瓜不打烊 compared the political rivals鈥 health care positions, showing how their policies have helped 鈥 or hindered 鈥 the health of their states鈥 residents.
By Daniel Chang and Angela Hart -
Evolving Overdose Crisis Shakes Previously Effective Treatments
The prevalence of synthetic drugs is undercutting a previously effective and widely embraced opioid use disorder treatment tactic. Now, the model pioneered in Vermont a decade ago and adopted at sites nationwide, especially in hard-to-reach rural areas, is being forced to evolve.
By Taylor Sisk -
Journalists Delve Into Open Enrollment, School Nurse Shortages, and More
吃瓜不打烊 and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
-
Beyond Insulin: Medi-Cal Expands Patient Access to Diabetes Supplies
California鈥檚 Medicaid program is making it easier for people with diabetes to obtain the supplies and equipment they need to manage their blood sugar, partly by relaxing preauthorization requirements that can cause life-threatening delays.
By Angela Hart -
Biden Administration鈥檚 Limit on Drug Industry Middlemen Backfires, Pharmacists Say
A rule taking effect Jan. 1 was intended to stop one set of abuses by pharmacy benefit managers, or PBMs, but some pharmacists say it鈥檚 enabling these price brokers to simply do new things unfairly.
By Arthur Allen -
A New RSV Shot Could Help Protect Babies This Winter 鈥 If They Can Get It in Time
Supply problems, a high price tag, and bureaucratic obstacles are slowing the distribution of a therapy that can protect infants from the respiratory syncytial virus. That will leave them unnecessarily at risk of hospitalization this winter, pediatricians fear.
-
US to Cover HIV Prevention Drugs for Older Americans to Stem Spread of the Virus
The government has proposed that Medicare fully cover preexposure prophylaxis drugs that prevent HIV, a change that could help America catch up with nations in Europe and Africa that are on track to end new infections decades before the U.S. under its current approach.
John Green vs. Johnson & Johnson (Part 2)
Season 10, Episode 3The high price of lifesaving tuberculosis drugs makes them inaccessible to many who need them most. On this episode of 鈥淎n Arm and a Leg,鈥 hear how a decades-long global fight to reform drug patents is helping to lower the cost.
-
News Analysis
A New Era of Vaccines Leaves Old Questions About Prices Unanswered
The CDC鈥檚 RSV vaccination recommendations beg the question: How much should an immunization that will possibly be given to millions of Americans cost to be truly valuable?
The New Speaker鈥檚 (Limited) Record on Health
Episode 320The House finally has a new speaker: Mike Johnson (R-La). He鈥檚 a relative newcomer who鈥檚 been a lower-level member of the House GOP leadership. And while he鈥檚 an outspoken opponent of abortion and same-sex marriage, his record on other health issues is scant. Meanwhile, the National Institutes of Health appears on track to be getting a new director, and Georgia鈥檚 Medicaid work requirement experiment is off to a very slow start. Alice Miranda Ollstein of Politico and Rachel Cohrs of Stat join 吃瓜不打烊鈥 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Michael Cannon, director of health policy studies at the Cato Institute, a libertarian think tank.
-
California Expands Paid Sick Days and Boosts Health Worker Wages
Gov. Gavin Newsom signed legislation expanding paid sick leave to five days, extending bereavement leave to miscarriages and failed adoptions, and approving an eventual $25-an-hour health care minimum wage. Still, in a possible sign of national ambitions, the Democrat vetoed free condoms in schools and refused to decriminalize psychedelic mushrooms.
By Don Thompson